HSD17B13 / Hydroxysteroid 17-beta dehydrogenase 13 (NAFLD / NASH Marker) Antibody
Product Sizes
20 ug
£364.00
345275-MSM6-P0-20UG
About this Product
- SKU:
- 345275-MSM6-P0
- Additional Names:
- 7-beta-hydroxysteroid dehydrogenase 13; 17-beta-HSD 13; Short chain dehydrogenase/reductase family 16C member 3; Short-chain dehydrogenase/reductase 9; SDR16C3 SCDR9; HMFN0376 UNQ497/PRO1014; HSD17B13
- Application:
- Immunohistochemistry
- translate.label.attr.clone:
- HSD17B13/13106
- Clonality:
- Monoclonal
- Extra Details:
- Hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) is an engyme in the liver that is associated with lipid droplets. It is encoded by the HSD17B13 gene in humans. HSD17B13 levels increase in patients with non-alcoholic fatty liver disease (NAFLD) and can enhance lipogenesis. However; some studies have shown that loss-of-function variants in HSD17B13 may protect against the progression of NAFLD to non-alcoholic steatohepatitis; fibrosis; and hepatocellular carcinoma.
- Host:
- Mouse
- Immunogen:
- Recombinant fragment (around aa1-200) of human HSD17B13 protein (exact sequence is proprietary)
- Isotype:
- IgG2b
- Molecular Weight:
- 30kDa
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
- Supplier:
- NeoBiotechnologies
- Type:
- Antibodies: Monoclonal Antibody
- Manufacturer's Data Sheet:https://www.neobiotechnologies.com/download-datasheet/?PID=142228
